Myriad Genetics: A 45.5% Better Bargain Than When Gilbert Bought
May 08, 2020 at 16:17 PM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on December 13, Myriad Genetics, Inc.'s Director, Walter Phd Gilbert, invested $149,997.83 into 5,860 shares of MYGN, for a cost per share of $25.60..
